Form 8.3 - WILLIS TOWERS WATSON PLC

LONDON--()-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 11 June 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

1,879,819

1.46%

231,625

0.18%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

72,359

0.06%

94,581

0.07%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,958,278

1.52%

332,306

0.26%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit

Purchase

1

256.5200 USD

Purchase

1

258.8200 USD

Purchase

1

259.1400 USD

Purchase

1

257.5000 USD

Purchase

2

256.8400 USD

Purchase

5

256.7800 USD

Purchase

6

257.0900 USD

Purchase

12

257.2150 USD

Purchase

12

257.1250 USD

Purchase

13

256.7750 USD

Purchase

14

257.3400 USD

Purchase

16

259.0325 USD

Purchase

18

257.1733 USD

Purchase

20

257.1055 USD

Purchase

22

257.0500 USD

Purchase

22

257.0686 USD

Purchase

28

257.3246 USD

Purchase

28

257.2653 USD

Purchase

34

257.8900 USD

Purchase

36

257.1077 USD

Purchase

42

257.3071 USD

Purchase

50

256.8600 USD

Purchase

100

257.7200 USD

Purchase

100

256.6100 USD

Purchase

100

256.8054 USD

Purchase

108

256.8000 USD

Purchase

260

257.1943 USD

Purchase

268

258.6462 USD

Purchase

283

257.6414 USD

Purchase

303

258.2385 USD

Purchase

368

257.0490 USD

Purchase

372

258.1951 USD

Purchase

373

257.7167 USD

Purchase

581

257.4912 USD

Purchase

792

257.4017 USD

Purchase

931

258.1352 USD

Purchase

977

257.9064 USD

Purchase

2,204

257.7030 USD

Purchase

2,809

257.5012 USD

Purchase

3,352

257.6378 USD

Purchase

5,021

257.8599 USD

Purchase

5,701

258.7173 USD

Purchase

8,053

257.9764 USD

Purchase

9,191

257.4900 USD

Purchase

9,749

258.1731 USD

Purchase

10,508

257.6878 USD

Purchase

14,500

257.6789 USD

Sale

6

257.6191 USD

Sale

8

257.4712 USD

Sale

11

257.4354 USD

Sale

13

256.9000 USD

Sale

13

256.9700 USD

Sale

13

257.1300 USD

Sale

14

257.4407 USD

Sale

16

257.4800 USD

Sale

16

257.5493 USD

Sale

19

257.5868 USD

Sale

20

257.1700 USD

Sale

21

257.5659 USD

Sale

25

257.7520 USD

Sale

25

257.6034 USD

Sale

26

256.8500 USD

Sale

26

257.0800 USD

Sale

26

256.7750 USD

Sale

33

257.8683 USD

Sale

34

257.8900 USD

Sale

61

258.7600 USD

Sale

80

257.1721 USD

Sale

82

256.7900 USD

Sale

90

258.9633 USD

Sale

100

257.0900 USD

Sale

111

257.6100 USD

Sale

184

257.0490 USD

Sale

298

258.0470 USD

Sale

510

258.1390 USD

Sale

520

257.1943 USD

Sale

603

257.5332 USD

Sale

1,416

257.4021 USD

Sale

1,689

257.6495 USD

Sale

2,104

257.7322 USD

Sale

2,623

257.4968 USD

Sale

2,842

257.5479 USD

Sale

11,682

257.6981 USD

Sale

11,778

258.3941 USD

Sale

17,332

257.4900 USD

Sale

23,773

258.0053 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

14 Jun 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

Category Code: RET
Sequence Number: 739245
Time of Receipt (offset from UTC): 20210614T104240+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC